I Know First Review: August 29th, 2016

I Know First Review

The stocks selected here are the top performing stocks from I Know First: Daily Market Forecast’s August 28th, 2016 stock forecast titled, “Stock Picker Based on Big Data: 43% Return In 14 Days.”

This forecast is part of the “Stocks Under 10 Dollars” package, as one of I Know First’s quantitative investment solutions. The “I Know First Average” return was 16.72% in 14 days, against the S&P 500’s return of 0.28% over the same time period.

I Know First Review

Learn how to read the predictions: Instructions

Learn how to strategize with the forecast: Algorithmic Trading Strategies 

Please note-for trading decisions use the most recent forecast. Get today’s forecast and Top stock picks.

Screen Shot 2016-08-29 at 1.43.33 PM

Signal: 12.90

Predictability: 0.12

Return: 42.26%

Bovie Medical Corporation (BVX), a medical device company, develops, manufactures, and markets electrosurgical devices and related medical products used in doctor’s offices, surgery centers, and hospitals worldwide. In accordance with the algorithm’s prediction, the stock price had increased 42.26% in a mere 14 day period. The increase is mainly due to an increase in insider trading in a positive sentiment, increase in shares being bought. This has caused a positive momentum movement over the past few weeks.

Screen Shot 2016-08-29 at 1.50.33 PM

Signal: 5.69

Predictability: 0.13

Return: -7.07%

Clean Diesel Technologies (CDTI) manufactures and distributes light duty vehicle catalysts and heavy duty diesel emissions control systems and products to automakers, distributors, integrators, and retrofitters in the United States, Canada, Sweden, and the United Kingdom.  The stock saw a decline of 7.07% during the 14 day period. The decline was due to uncertainty sentiment in the commodity prices during this time, specifically with a decline in crude oil prices.

Screen Shot 2016-08-29 at 1.53.43 PM

  Signal: 5.40

  Predictability: 0.30

  Return: 10.91%

Titan International, Inc. (TWI), together with its subsidiaries, manufactures and sells wheels, tires, wheel and tire assemblies, and undercarriage systems and components for off-highway vehicles in the United States and internationally. The I Know First algorithm had correctly predicted the stock return of 10.91%. This increase was due to a 20% positive surprise in earnings reported for the past quarter.


Screen Shot 2016-08-29 at 2.53.13 PM

Signal: 4.72

Predictability: 0.12

Return: 0.86%

Sequenom, Inc.(SQNM), a life sciences company, engages in the provision of early patient management information. It develops and commercializes molecular diagnostic testing services that serve women’s health and oncology markets, both US markets and international ones as well. I Know First forecasted a positive return correctly as the stock price increased by 0.86%. The increase can be mainly attributed to reported of -$0.05 EPS, demonstrating earnings are reverting towards a positive stance.

Screen Shot 2016-08-29 at 2.59.59 PM

Signal: 4.62

Predictability: 0.17

Return: 7.43%

STAAR Surgical Company, designs (STAA), develops, manufactures, and sells implantable lenses for the eye, and delivery systems to deliver the lenses into the eye. I Know First’s algorithm correctly predicted an increase of 7.43%. This occurred due rec0rd quarterly performance, as a result of an increase in demand across Europe and Asia, for the ICL product. 

Screen Shot 2016-08-29 at 3.10.58 PM

Signal: 4.39

Predictability: 0.23

Return: 28.17%

Pixelworks, Inc. (PXLW), designs and develops video and pixel processing semiconductors, intellectual property cores, software, and custom ASIC solutions for digital video applications. The Company’s solutions enable the visual display of broadband content through a variety of electronic devices. In accordance with the algorithm’s prediction, the stock price increased 28.17%, in a mere 14 day period. This is due to positive investor sentiment of an increase in target prices for the firm, due to them posting higher earnings than the conesus estimate by $.05 EPS.

Screen Shot 2016-08-29 at 3.17.52 PM

Signal: 4.29

Predictability: 0.25

Return: 43.29%

Ocwen Financial Corp. (OCN), is a provider of residential and commercial mortgage loan servicing, special servicing and asset management services. The I Know First algorithm accurately predicted a positive return of 43.29%. The positive return was as a result of new reports showing an increase in housing and mortgage demand.

Screen Shot 2016-08-29 at 3.27.15 PM

Signal: 4.19

Predictability: 0.30

Return: 26.73%

Kratos Defense & Security Solutions, Inc. (KTOS) is a mid-tier government contractor at the forefront of the Department of Defense’s Third Offset Strategy. The Company is a leading technology, intellectual property and proprietary product and solution based business, addressing the United States and its allies’ National Security priorities. The stock price rose 26.73% during the 14 day period, as predicted by I Know First’s algorithm. This is due to better than expected reported EPS, of $0.17, as well as an almost 5% increase in quarterly revenues year on year; which is due to an increase demand in their defense products as the US foreign policy shifts away from a focus on ground invasion.

Screen Shot 2016-08-29 at 3.34.41 PM

Signal: 3.38

Predictability: 0.24

Return: 3.94%

Liquidity Services, Inc is an online auction marketplace for surplus and salvage assets. The Company operates through the operating auction marketplaces for sellers and buyers of surplus, salvage and scrap assets segment. LCDT’s stock price increased by 3.94% as indicated by I Know First’s algorithm. This was as a result in superb quarterly earnings of $0.07 EPS, that had beaten the conesus estimate of -$0.09 EPS.

Screen Shot 2016-08-29 at 3.52.35 PM

Signal: 3.06

Predictability: 0.13

Return: 10.74%

BioCryst Pharmaceuticals, Inc. (BCRX) a pharmaceutical company headquartered in North Carolina, designs, optimizes and develops novel small-molecule drugs that block key enzymes to treat rare diseases. The stock price increased 10.74% as predicted by the algorithm. This was as a result of positive news of completion APeX-1 clinical trial of BCX7353 for the oral treatment of hereditary angioedema (HAE).

Business Disclosure: I Know First Research is the analytic branch of I Know First, a financial startup company that specializes in quantitatively predicting the stock market. We did not receive compensation for this article, and we have no business relationship with any company whose stock is mentioned in this article.